Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-13

Clinical Trial Update: Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing tamoxifen with LY353381 in women with newly diagnosed breast cancer has completed. The update indicates the study has finished, withou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LY353381
  • Tamoxifen (tamoxifen)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED